Michael Harsh, Director at ENDRA Life Sciences Inc. (NDRA), bought 500 shares at $1.14 ($570) on 2019-06-10, disclosed to the SEC on 2019-06-14.
Open-market purchase of $570 NDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.